Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)

NCT04797299 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 526

Last updated 2025-09-25

No results posted yet for this study

Summary

To evaluate whether the combination of clinicopathological factors and the use of the Oncotype DX DCIS score can avoid radiation in women with low risk DCIS who have had breast conserving surgery (BCS)

Conditions

  • DCIS

Sponsors & Collaborators

  • Ontario Clinical Oncology Group (OCOG)

    lead OTHER

Principal Investigators

  • Eileen Rakovitch, M.D. · Sunnybrook Research Institute, Sunnybrook Health Science

  • Tim Whelan, M.D · Juravinski Cancer Centre

Eligibility

Min Age
46 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-23
Primary Completion
2030-11-30
Completion
2035-11-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04797299 on ClinicalTrials.gov